We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+8.06%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$66.5B
AUM Growth
+$8.68B
Cap. Flow
+$4.4B
Cap. Flow %
6.62%
Top 10 Hldgs %
43.86%
Holding
2,667
New
353
Increased
1,277
Reduced
719
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 4.02%
2 Financials 2.97%
3 Healthcare 1.72%
4 Consumer Discretionary 1.4%
5 Consumer Staples 1.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBX
2251
Wallbox
WBX
$95.3M
$39.8K ﹤0.01%
556
+45
+9% +$5.1K
AGEN
2252
Agenus
AGEN
$249M
$39.5K ﹤0.01%
+839
New +$42.6K
KPTI icon
2253
Karyopharm Therapeutics
KPTI
$168M
$39.4K ﹤0.01%
773
ONCT
2254
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$39.3K ﹤0.01%
1,966
-6
-0.3% -$119
FAX
2255
abrdn Asia-Pacific Income Fund
FAX
$590M
$39.2K ﹤0.01%
2,482
-11,899
-83% -$179K
GOOG icon
2256
PUT
Alphabet (Google) Class C
GOOG
$3.9T
$39K ﹤0.01%
7,500
+1,500
+25% +$143K
OCUL icon
2257
Ocular Therapeutix
OCUL
$1.86B
$38.9K ﹤0.01%
13,839
-1,555
-10% -$5.15K
FIRY
2258
Firy Inc
FIRY
$127M
$38.7K ﹤0.01%
3,823
-3,000
-44% -$55.1K
BRK.B icon
2259
PUT
Berkshire Hathaway Class B
BRK.B
$1.07T
$38.1K ﹤0.01%
16,400
+13,700
+507% +$4.07M
TEAD
2260
Teads Holding Co
TEAD
$75.2M
$37.4K ﹤0.01%
+10,335
New +$40.5K
NUVB icon
2261
Nuvation Bio
NUVB
$2.24B
$37.1K ﹤0.01%
19,328
+7,249
+60% +$14.7K
AIRS icon
2262
AirSculpt Technologies
AIRS
$325M
$37K ﹤0.01%
10,000
IAG icon
2263
IAMGOLD
IAG
$8.47B
$37K ﹤0.01%
14,337
+3,712
+35% +$6.45K
LCI
2264
DELISTED
Lannett Company, Inc.
LCI
$37K ﹤0.01%
17,750
+5,250
+42% +$11.3K
AMRN
2265
Amarin Corp
AMRN
$284M
$36K ﹤0.01%
1,489
-136
-8% -$3.27K
SPXL icon
2266
CALL
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.58B
$35.5K ﹤0.01%
+7,300
New +$471K
IDEX
2267
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$35.2K ﹤0.01%
1,719
QQQ icon
2268
CALL
Invesco QQQ Trust
QQQ
$455B
$35K ﹤0.01%
900
-700
-44% -$194K
EAR
2269
DELISTED
Eargo, Inc. Common Stock
EAR
$34.9K ﹤0.01%
3,033
FTEK icon
2270
Fuel Tech
FTEK
$48.2M
$34.9K ﹤0.01%
27,350
CRDF icon
2271
Cardiff Oncology
CRDF
$64.3M
$34.3K ﹤0.01%
24,500
-1,075
-4% -$1.54K
QVCGA
2272
DELISTED
QVC Group Inc Series A
QVCGA
$34.3K ﹤0.01%
+420
New +$42.8K
REAX icon
2273
Real Brokerage
REAX
$368M
$34.1K ﹤0.01%
32,500
-873
-3% -$1.18K
SWIM icon
2274
Latham Group
SWIM
$646M
$33.8K ﹤0.01%
10,508
+508
+5% +$1.83K
SPY icon
2275
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$33.5K ﹤0.01%
3,200
-7,500
-70% -$2.88M

Similar funds

Creative Planning's Q4 2022 Portfolio in Review

As of Q4 2022, Creative Planning held 2,667 positions worth $66.5B, up 15% from $57.8B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Creative Planning deployed $4.4B of net new capital in Q4 2022, opening 353 new positions and adding to 1,277 existing holdings. Its largest new stake was Avantis US Equity ETF: 4,140,930 shares worth $282M.

By sector, the portfolio is most concentrated in Technology at 4% of assets, down from 4.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 ETF, an estimated $76.1M trimmed.

  • Creative Planning's largest Q4 2022 buy was Avantis US Equity ETF: 4,140,930 shares worth $282M.
  • Creative Planning added most to iShares Core MSCI International Developed Markets ETF in Q4 2022, an estimated $322M increase.
  • Creative Planning's biggest Q4 2022 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $76.1M.
  • Creative Planning fully exited Veradigm Inc. Common Stock in Q4 2022, selling an estimated $19.6M.
  • Creative Planning's ten largest holdings make up 44% of its $66.5B portfolio in Q4 2022.
  • Creative Planning opened 353 new positions and closed 180 in Q4 2022.
  • Creative Planning's portfolio value rose 15% quarter-over-quarter to $66.5B.

Based on Creative Planning's 13F filing for Q4 2022, filed 10 Feb 2023.